Biggest News Aggregation in the World
📰 Recommendations From News

Recommendations From News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Recommendations From. Real-time updates on events, politics, business and more.

Expanded CGM Access Could Usher in New Era of Diabetes Management

Expansions in access by the Centers of Medicare and Medicaid Services could bring the latest advances in continuous glucose monitoring into the hands of millions with diabetes, which could provide significant, population-level impact and bring the field a step closer to equitable diabetes management.
United States Christine Schumacher Medtronic Minimed Eliud Kipchoge Medtronic Guardian Williamt Dahms

Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials

After achieving primary endpoint by demonstrating superiority and non-inferiority in HbA1C reduction from baseline at week 52, investigative insulin icodec helped patients achieve significantly more time in target blood glucose range (Time in Range) vs once-daily basal insulin glargine U100 in ONWARDS 11In the ONWARDS 1 and 3 trials, more people achieved blood glucose targets without clinically significant or severe hypoglycaemia with once-weekly basal insulin icodec vs once-daily basal insulin
San Diego United States American Diabetes Association Scientific Sessions Of The American Diabetes Association Novo Nordisk Annual Scientific Sessions
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials

After achieving primary endpoint by demonstrating superiority and non-inferiority in HbA1C reduction from baseline at week 52, investigative insulin icodec helped patients achieve significantly more time in target blood glucose range (Time in Range) vs once-daily basal insulin glargine U100 in ONWARDS 11In the ONWARDS 1 and 3 trials, more people achieved blood glucose targets without clinically significant or severe hypoglycaemia with once-weekly basal insulin icodec vs once-daily basal insulin
United States San Diego Scientific Sessions Of The American Diabetes Association American Diabetes Association Novo Nordisk Annual Scientific Sessions
Source: yahoo.com

Raising Vape Sale Age To 21 Among Recommendations From ASH To Tackle Youth Vaping Numbers

Action for Smokefree 2025 (ASH) has outlined new proposals to help tackle youth vaping in New Zealand. “We do not want young people, most of whom have never smoked, to vape, but youth vaping is not a simple ‘one size fits all’ problem,” ASH ...
New Zealand Vaping Numbersmonday Ben Youdan Zealand Health Recommendations From Tackle Youth Vaping Numbersmonday

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science